Location:Home » Cancer Education » Anthracyclines, Anti-Aromatase Agents, and COX-2 Inhibitors in Breast Cancer Therapy: A Critical Appraisal By Key Opinion Leaders
Anthracyclines, Anti-Aromatase Agents, and COX-2 Inhibitors in Breast Cancer Therapy: A Critical Appraisal By Key Opinion Leaders